Tuberculosis (TB) is a serious public-health problem, with increasing mortality rates worldwide ([@B28]). The search for new drugs to treat TB is of paramount importance in view of the present long-term combination therapy, the large number of side effects associated with most drugs and the continuous selection of resistant strains ([@B1], [@B15]).

Species from the genus Calophyllum sp. (Clusiaceae) have aroused interest from the scientific community because of promising results from chemical and biological aspects. This genus is rich in secondary metabolites such as steroids, triterpenes, coumarins, benzopyrans and several types of xanthones and proanthocyanins, some of which possess antibacterial potential ([@B10]). The pyranocoumarin (+)-calanolide A from Calophyllum lanigerum showed significant activity against Mycobacterium tuberculosis, including multidrug-resistant (MDR) strains, with a minimal inhibitory concentration (MIC) of 3.13 µg/mL and anti-human immunodeficiency virus (HIV)-1 activity, indicating a new class of compounds that can be used to treat patients co-infected with HIV/TB ([@B29]).

Calophyllum brasiliense Cambess (Clusiaceae) is a large tree that is widely distributed in the Americas. It grows in tropical forests from Mexico to Brazil, where it is known as "Guanandi" ([@B7]). In Brazil folk medicine, infusions prepared from the stem bark are used in the treatment of rheumatism, varicosis, haemorrhoids, chronic ulcers ([@B7]), bronchitis, gastric and hepatic disturbances ([@B19]) and pain ([@B16]).

C. brasiliense has proven to be a rich source of bioactive compounds, including the coumarins mammea A/BA, mammea A/BB (1), mammea A/AA, mammea C/OA and mammea C/OB, which act against Staphylococcus aureus ([@B25], [@B30]). Some chromanone acids isolated from C. brasili- ense bark showed moderate to strong activity against Bacillus cereus and Staphylococcus epidermidis ([@B8]). Assays using methanolic extracts of the roots, stems, leaves, flowers and fruits from C. brasiliense indicated that all parts of the plant exhibited activity against Gram-positive bacteria (B. cereus, S. aureus, Staphylococcus saprophyticus and Streptococcus agalactiae). No activity was observed against Gram-negative bacteria (Enterobacter cloacae, Escherichia coli, Proteus mirabilis, Pseudomonas aeruginosa and Salmonella typhimurium) and yeasts (Candida albicans and Candida tropicalis) ([@B23]). Other studies have shown that the extracts, especially the coumarin (-) (1) isolated from C. brasiliense leaves, possess potent antileishmanial activity ([@B4], [@B2], [@B3], [@B6], [@B13], [@B27]).

The aim of the present study was to assess the in vitro antimycobacterial activity and cytotoxicity of the dichloromethane extract and the compounds (1), (-) mammea B/BB (2) and amentoflavone (3) obtained from the leaves of C. brasiliense.

MATERIALS AND METHODS
=====================

Plant material - C. brasiliense leaves were collected in Cardoso Island, December 2010, in the state of São Paulo (SP), Brazil. The voucher specimen (SP 363818) was identified by Prof Dr Maria Claudia M Young and was deposited and authenticated at the Herbarium of the Botany Institute of São Paulo, SP. The leaves were dried at 35ºC in a circulating air oven and triturated in a knife mill (Usiram, São Bernardo do Campo, SP).

Plant extraction and purification of compounds - The powdered leaves (800 g) were extracted by exhaustive maceration in ethanol/water (9:1) at room temperature (RT), filtered and concentrated under vacuum at 40ºC to obtain an aqueous extract and a dark-green residue. The aqueous extract was lyophilised (121.3 g). The dark-green residue from the extract, which had adhered to the glass bottles, was dissolved with dichloromethane and the solvent was completely evaporated at RT to yield a dichloromethane extract (25.0 g) ([@B4], [@B2], [@B3]).

The dichloromethane extract (25.0 g) was initially fractionated using chromatography in a vacuum silica-gel column (8.0 × 40 cm) with hexane, hexane/dichloromethane (1:1), dichloromethane, dichloromethane/ethyl acetate (9:1), ethyl acetate, methanol and methanol/water (9:1). Next, the hexane fraction (4.0 g) was further chromatographed on a vacuum silica-gel column and eluted with hexane, hexane/dichloromethane (98:2, 95:5, 90:10, 80:20 and 50:50), dichloromethane, dichloromethane/ethyl acetate (98:2, 95:5, 90:10, 80:20 and 50:50), ethyl acetate and methanol. The hexane fraction was evaporated to a residue, which was crystallised using dichloromethane (9:1), yielding compound (1) (52.0 mg), as described in previous studies (Gasparotto-Júnior et al. 2005, [@B4], [@B2], [@B3]). Fractions 6-8 (667.0 mg), which were eluted in hexane, were chromatographed using thin layer chromatography and combined and then rechromatographed on a silica-gel column chromatograph (40 × 2.0 cm) eluted with hexane, hexane/dichloromethane (98:2-50:50), dichloromethane, dichloromethane/ ethyl acetate (95:5-50:50), ethyl acetate and finally methanol. Next, fractions 1-12, which were eluted in hexane, were combined and evaporated to dryness, obtaining (2) (10.5 mg), as described in a previous study ([@B3]). The ethyl acetate fraction (1.83 g) of the dichloromethane extract was rechromatographed through a Sephadex LH-20 column and eluted with chloroform/methanol (1:1). Fractions 48-53 (223.8 mg) were identified as (3), as described in a previous study ([@B2]).

Structure elucidation - The compounds were identified by chromatography-mass spectrometry in a Shimadzu GC/MS 17 A QP 5000 mass spectrometer, DB5 column (30 m; 0.32 µm) and a Micromass Quattro-LC instrument equipped with an ESI/APCI Z-spray ion source and by nuclear magnetic resonance (NMR) obtained in a Bruker DRX-400 (8.4 T) and Gemini 300 (7.05T), with TMS as the internal standard and a constant temperature of 298 K. 1H NMR (300 MHz), 13C NMR (75.5 MHz), DEPT, COSY (300 MHz), HMBC and HSQC analysis was conducted using deuterated solvent (CDCl3). The αD was obtained using a Perkin-Elmer Model 241 polarimeter (20ºC; 589 nm) with dichloromethane and was compared with data from the literature (Gasparotto-Júnior et al. 2005, [@B2], [@B3], [@B5]).

Spectroscopic and spectrometry data - The spectroscopic and spectrometry data of compounds (1), (2) and (3) ([Fig. 1](#f01){ref-type="fig"}) were obtained from previous studies (Gasparotto-Júnior et al. 2005, [@B2], [@B3], [@B5], respectively).

Fig. 1: pure compounds isolated from leaves of Calophyllum brasiliense: (-) mammea A/BB (1), (-) mammea B/BB (2) and amentoflavone (3).

High performance liquid chromatography coupled to a ultraviolet detector (HPLC-UV) analysis - The dichloromethane extract and purified compounds were analysed by HPLC-UV using HPLC-UV grade solvents and ultrapure water (Milli-Q system, Millipore, Bedford, MA, USA) and a Waters 1525 liquid chromatograph equipped with a binary pump (LC-10 AD), automatic injection valve 135 (Rheodyne) with a 20 µL loop, CTO-10AVP thermostat-controlled oven compartment (Shimadzu) and a 2489 UV/visible detector (Waters) controlled by Breeze 2 software (OmniSolv EM Science, Gibbstown, NJ, USA). A MetaSil ODS column (5 µm; 150 × 4.6 mm) maintained at 25ºC was used in the chromatographic analysis. The separation was conducted in a gradient system, using a mixture of acetonitrile and ultrapure water 55:45 v/v to 80:20 (0-10 min), 80:20 v/v to 100% (10-20 min), 100% acetonitrile (20-25 min) and 55:45 v/v (26-30 min) as the mobile phase, at a flow rate of 0.6 mL/min. Detection was performed at 336 nm and the running time was 30 min. The sample injection volume was 20 µL. The dichloromethane extract (3 mg/mL) and purified compounds (1), (2) and (3) (1 mg/mL) were dissolved in methanol, filtered through a membrane filter (Millipore, Brazil) and injected (20 µL) into the HPLC-UV system. Compounds (1) and (2) were quantified in the dichloromethane and aqueous extracts by HPLC-UV using compound (1) isolated from the C. brasiliense leaves as the standard. The content of (2) was calculated using the calibration curves of compound (1); these compounds belong to the same coumarin class and produced UV-spectra with almost the same molar absorptivity at 254 and 366 nm ([@B9], Gasparotto-Júnior et al. 2005). For the calibration curves of compound (1), solutions in methanol were used at concentrations ranging from 15.63-250 µg/mL. The extracts were prepared in methanol at 3 mg/mL and filtered through a 0.45-µm membrane filter (Millipore, Brazil). Three determinations were carried out for each sample. The statistical analyses of the data were performed using Statistica 8.0 software (Statsoft Inc, Tulsa, OK, USA).

Determination of antimycobacterial activity - To determine the MIC against M. tuberculosis H37Rv (ATCC 27294), the dichloromethane and aqueous extracts from C. brasiliense leaves and purified compounds (1), (2) and (3) were subjected to in vitro assays in triplicate. Additionally, the pure compounds were tested against 13 clinical isolates (6 susceptible and 7 resistant). The clinical isolates were obtained from the mycobacteria collection of the Laboratory of Medical Bacteriology of the State University of Maringá, state of Paraná, Brazil. The antimycobacterial activity was evaluated using REMA, according to the procedure by [@B21] and [@B26]. Briefly, 200 µL of sterile distilled water was distributed into the outer wells of a microplate (Falcon 3072, Becton-Dickinson, Lincoln Park, NJ, USA). The extracts and pure compounds were diluted in dimethyl sulphoxide (DMSO) (Amresco) and serial two-fold dilutions from 1,000-7.8 µg/mL and 250-1.9 µg/mL, respectively, were made in Middlebrook 7H9 (Difco Laboratories, Detroit, MI, USA) supplemented with oleic acid, bovine albumin, dextrose and catalase (OADC) enrichment (BBL/Becton-Dickinson, Sparks, MD, USA). Isoniazid (Difco) was used as the reference drug at concentrations from 1.0-0.007 µg/mL. One hundred microlitres of each bacterial inoculum, standardised according to 1 McFarland turbidity and diluted 1:20 in Middlebrook 7H9 medium supplemented with OADC, was inoculated into the wells. A growth control containing no drug and a sterile control without bacteria were prepared for each assay. A control containing 2.5 % (v/v) DMSO was included to detect inhibitory effects on M. tuberculosis growth. The plates were covered with lids and the edges were sealed with polyethylene tape. The plates were placed in a plastic box and incubated at 35ºC at normal atmosphere for seven days. Next, 30 μL of freshly prepared 0.01% resazurin solution (Acros, Morris Plains, NJ, USA) was added to each well and the plates were reincubated for 24-48 h at 35ºC for visual readings. A colour change from blue to pink indicated mycobacterial growth and the MIC was interpreted as the lowest concentration that prevented the colour change.

Cytotoxicity assay - In vitro cytotoxicity assays were performed on J774G.8 macrophages ([@B22]). The macrophages were maintained in tissue flasks containing RPMI-1640 medium (Gibco, Invitrogen Co, Grand Island, NY, USA) with L-glutamine and supplemented with 10% inactivated foetal bovine serum (FBS) (Gibco BRL, Life Technologies) at 37ºC in a 5% CO2 atmosphere. The macrophages were plated at 5.0 × 104 cells per well in a 96-well microplate with RPMI-1640 medium supplemented with 10% inactivated FBS and incubated for 24 h at 37ºC in 5 % CO2. Next, the medium was removed and the cell monolayers were treated with different concentrations of the extracts and pure compounds (500-3.12 µg/mL). Positive and negative controls (without drugs) were included. The microplate was incubated under the same conditions for 48 h. Subsequently, 3-(4,5-dimethyl thiazol-2-yl)-2,5-diphenyl tetrazolium bromide dissolved in phosphate buffered saline at a concentration of 2 µg/mL was added to all of the wells except the reaction blank ([@B18]). The microplate was incubated in the absence of light under 5% CO2 at 37ºC for 4 h. Next, 150 μL of DMSO was added and stirred and the optical density was determined using an automated spectrophotometer (Asys Expert Plus) at 492 nm. The 50% cytotoxicity concentration (IC50) was determined by logarithm regression analysis. The selectivity index (SI) was determined using the IC50/MIC ratio for each compound tested.

RESULTS
=======

The dichloromethane extract showed activity against M. tuberculosis H37Rv with a MIC of 62.5 µg/mL. The aqueous extract showed lower activity (MIC 125 µg/mL) ([Table I](#t01){ref-type="table"}).

TABLE IAnti-Mycobacterium tuberculosis H37Rv activity and cytotoxicity of extracts and pure compounds obtained from leaves of Calophyllum brasilienseExtracts/compoundsMIC µg/mL (µM)IC50 µg/mL ± SD (µM ± SD)SIExtracts Dichloromethane62.536.67 ± 4.710.59 Aqueous125.0NTNTPure compounds (-) mammea A/BB31.2 (76.85)33.30 ± 3.30 (82.51 ± 8.0)1.06 (-) mammea B/BB31.2 (83.87)27.50 ± 2.50 (73.92 ± 6.7)0.88 Amentoflavone\> 500NTNT[^1]

The fractionation of the dichloromethane extract led to the isolation of the coumarins (1) and (2) and the biflavonoid (3), with the last one as the major constituent of the extract ([Fig. 1](#f01){ref-type="fig"}). The spectral data of the compounds were in agreement with the literature (Gasparotto-Júnior et al. 2005, [@B4], [@B2], [@B3], [@B5]).

The dichloromethane and aqueous extracts were analysed using HPLC-UV. These extracts displayed similar chromatographic profiles at 336 nm. In both extracts, we identified compounds (1) (peak 1), (2) (peak 2) and (3) (peak 3) with retention times of 21.0, 15.5 and 5.5 min, respectively ([Fig. 2](#f02){ref-type="fig"}). For the determination of the contents of compounds (1) and (2) in the extracts from C. brasiliense, the regression equation y = 61589x + 52298 was used, which showed different concentrations of the compounds. The dichloromethane extract showed a significantly higher concentration of compound (1) (31.86 ± 2.6 µg/mg) than the aqueous extract (16.67 ± 1.4 µg/mg) (p \< 0.001). Compound (2) was detected at a concentration of 8.24 ± 1.1 µg/mg in the dichloromethane extract, but it was not possible to quantify (2) in the aqueous extract. Compound (3) was not quantified because it did not demonstrate activity.

Fig. 2: chromatograms of the standard (-) mammea A/BB (Rt = 21.3 min) (A) and dichloromethane (B) and aqueous (C) extracts from leaves of Calophyllum brasiliense. Chromatographic conditions: MetaSil ODS column; mobile phase: acetonitrile-water 55:45 v/v to 80:20 (0-10 min), 80:20 v/v to 100% (10-20 min), 100% acetonitrile (20-25 min) and 55:45 v/v (26-30 min); flow rate 0.6 mL/min; temperature 25°C; detection: 336 nm; (1): (-) mammea A/BB; (2): (-) mammea B/BB; (3) amentoflavone.

Both coumarins (1) and (2) isolated from the dichloromethane extract showed anti-M. tuberculosis H37Rv activity, with a MIC of 31.2 µg/mL (76.85 µM) and 31.2 µg/mL (83.87 µM), respectively ([Table I](#t01){ref-type="table"}). Compound (3) showed low activity against M. tuberculosis H37Rv (MIC \> 500 µg/mL) ([Table I](#t01){ref-type="table"}).

We also evaluated the antimycobacterial activity of compounds (1) and (2) against six susceptible and seven resistant clinical M. tuberculosis isolates. The MIC values ranged between (1) 31.2 µg/mL (76.85 µM) and 62.5 µg/mL (153.94 µM) and (2) 31.2 µg/mL (83.87 µM) and 62.5 µg/mL (168.01 µM) ([Table II](#t02){ref-type="table"}).

TABLE IIAnti-Mycobacterium tuberculosis clinical isolates activity of isoniazid and pure compounds obtained from leaves of Calophyllum brasilienseM. tuberculosis clinical isolatesSusceptibility profileMICs µg/mL (µM)H(1)(2)1Susceptible0.03 (0.22)31.2 (76.85)31.2 (83.87)13638Susceptible0.03 (0.22)62.5 (153.94)62.5 (168.01)3Susceptible0.03 (0.22)31.2 (76.85)31.2 (83.87)11Susceptible0.03 (0.22)31.2 (76.85)31.2 (83.87)16Susceptible0.03 (0.22)31.2 (76.85)31.2 (83.87)4851Susceptible0.03 (0.22)62.5 (153.94)31.2 (83.87)1193H, R, E, S1 (7.29)62.5 (153.94)62.5 (168.01)91H, S2 (14.58)62.5 (153.94)31.2 (83.87)3614H, R, E, S, Et1 (7.29)31.2 (76.85)31.2 (83.87)4250H, R2 (14.58)31.2 (76.85)31.2 (83.87)73AH, R, Z4 (29.17)31.2 (76.85)31.2 (83.87)17H2 (14.58)62.5 (153.94)31.2 (83.87)40H, R2 (14.58)62.5 (153.94)31.2 (83.87)[^2]

The cytotoxicity assays, which were used to evaluate the safety of these compounds for mammalian cells, were performed only with the dichloromethane extract and pure compounds (1) and (2), which showed antimycobacterial activity. The dichloromethane extract and the pure compounds showed SI ranges from 0.59-1.06 ([Table I](#t01){ref-type="table"}).

DISCUSSION
==========

In the present study, we evaluated the antimycobacterial activity of dichloromethane and aqueous extracts from the leaves of C. brasiliense and pure compounds (1), (2) and (3) isolated from the dichloromethane extract.

No relevant difference in MIC values between the dichloromethane and aqueous extracts were detected against M. tuberculosis H37Rv in this study. The similarity in the MIC values for the nonpolar and polar extracts may be attributed to the coumarin contents in the aqueous extract, which was demonstrated by HPLC-UV, albeit at lower concentrations than that in dichloromethane extracts.

The MIC values of coumarins (1) and (2) isolated from the dichloromethane extract encourage us to consider these compounds as promising candidates for anti-TB drugs. Compound (3) showed a low activity against M. tuberculosis, which is in agreement with a previous study. In addition, [@B17], working with natural biflavonoids isolated from the seed kernels of Rhus succedanea and Garcinia multiflora, which included compound (3), observed no activity against M. tuberculosis H37Rv.

Although compounds (1) and (2) showed MICs higher than those of the reference drug isoniazid (MIC 0.01-0.2 µg/mL), these compounds are comparable to the MICs of other first-line anti-TB drugs, such as pyrazinamide (MIC 20-100 µg/mL at pH = 5.5 or 6.0) ([@B14]).

As observed in this study, the MIC values for the resistant isolates, of which five were MDR, were equivalent to those of the sensitive isolates. This encourages us to consider these compounds as potential candidates for the development of new anti-TB drugs that act against resistant bacilli. A drug that can target these bacilli is undoubtedly desirable because this severe form of TB has been increasing worldwide.

The SI is used to estimate the therapeutic window of a drug and to identify drug candidates for further studies. According to [@B20], [@B24] and [@B11], a candidate as a new drug must have an SI ≥ 10. The extract and pure compounds studied here exhibited lower SIs, indicating low therapeutic selectivity. However, these compounds deserve attention and, in the future, a microparticles study of these compounds, as well as the antitumour activity will be conducted.

Here we report the activity of extracts and coumarins from the leaves of C. brasiliense against M. tuberculosis. The results of this study provide a strong basis for the selection of new anti-TB drugs. Additional studies are required to increase the effectiveness of coumarins against M. tuberculosis and to decrease their toxicity to a host.
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[^1]: results are expressed as mean of experiments performed in triplicate. IC50: 50% cytotoxic concentration; MIC: minimal inhibitory concentration; NT: not tested; SD: standard deviation; SI: IC50/MIC.

[^2]: results are expressed as mean of experiments performed in triplicate. E: ethambutol; Et: ethionamide; H: isoniazid; MIC: minimal inhibitory concentration; R: rifampicin; S: streptomycin; Z: pyrazinamide; (1): (-) mammea A/BB; (2): (-) mammea B/BB.
